Merck Serono (Italy)
Merck Serono is a pharmaceutical company headquartered in Darmstadt, Germany, and a brand and division of Merck focused on biopharmaceuticals. In September 2006, Merck KGaA announced its intent to purchase the majority of Serono shares from Ernesto Bertarelli and the Bertarelli family. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Merck Serono (Italy), Italy, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
50%
Total
Publications
641
Total Open
Publications
319
Total
Citations
20K
Open Access
Percentage
50%
Total
Publications
641
Total Open
Publications
319
Total
Citations
20K
Breakdown
Publisher Open
13%
Both
31%
Other Platform Open
6%
Closed
50%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 51%
141
Hybrid 23%
64
No Guarantees 26%
72
Other Platform Open
Domain 65%
153
Institution 42%
99
Other Internet 26%
62
Public 4%
10
Preprint 3%
7
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 153 |
DOI | Other Internet | 62 |
Europe PMC | Domain | 20 |
University of Modena and Reggio Emilia | Institution | 19 |
University of Milan | Institution | 11 |
European Organization for Nuclear Research | Institution | 11 |
KU Leuven | Institution | 8 |
Figshare | Public | 8 |
University of Siena | Institution | 7 |
uniroma1.it OAI-PMH Repository | Institution | 7 |